PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 490.00
Ask: 491.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.204%)
Open: 485.00
High: 495.00
Low: 485.00
Prev. Close: 490.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Jan 2021 07:00

RNS Number : 5318M
Treatt PLC
22 January 2021
 

22 January 2021

TREATT PLC

("Treatt" or "the Group")

Trading update

Strong trading - profits expected to materially exceed market consensus

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today updates on trading since the start of its financial year ending 30 September 2021 ("FY21").

Highlights

· Strong operating performance across multiple categories and customers, with new organic revenue growth and enhanced margins from improving product mix.

· Profits for the first four months of the current financial year are expected to be ahead of Board's previous expectations for the period.

· Continued partnering with customers to develop exciting products in the fast-evolving beverages market is driving potential for further revenue and margin growth.

· Headwinds from COVID-19, the geopolitical landscape and commodity/currency risks remain.

· Overall, the Board is cautiously optimistic that the current strong momentum will result in profit before tax and exceptional items for FY21 materially exceeding the current market consensus* of £15.1m.

Trading performance

As reported in our FY20 results announcement on 24 November 2020, the Group had a strong start to the new financial year, and this has continued with the trading performance in the year to date being significantly better than expected.

The Group is performing particularly well in its citrus, health & wellness, fruit & vegetables and tea categories. Some material new business wins have been achieved including in the global alcoholic seltzer category which is continuing to grow strongly. Treatt is well positioned as a supplier of natural extracts including its sugar reduction solutions; the Group's technical expertise enables it to add significant value to customers across a growing range of applications resulting in margin expansion as well as revenue growth.

Whilst some parts of our product portfolio continue to be impacted from subdued on-trade demand due to the closure of venues in many parts of the World, this has been more than offset by increased demand from off-trade channels.

The Board considers that the strong trading momentum shown in these first few months of the current financial year will continue into H2 but is mindful that the Group faces the same uncertainties as our customers regarding the ongoing COVID-19 global pandemic, potential further lockdowns in our key markets and the volatile geopolitical landscape, with potential impacts on demand, FX rates and commodity prices. Nevertheless, the better than expected performance for the first four months of the year and the level of the order book leads the Board to be cautiously optimistic about continued growth in revenues, margins and profits for the rest of FY21, with profit before tax and exceptional items for FY21 expected to materially exceed current consensus* of £15.1m.

Daemmon Reeve, CEO, commented:

"We're encouraged by our strong trading momentum continuing into the current financial year. Performance has been positive across a number of our key categories, with particular growth in our solutions for the expanding alcoholic seltzer market, utilising our expertise in natural extracts.

"Whilst mindful of the global backdrop, we are confident that we can make further progress this year, to grow organic revenue across an increasingly global and diversified customer base who benefit from our technical expertise and value-add approach."

 

* Treatt compiled consensus of analyst forecasts for FY21 of profit before tax and exceptional items.

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

Alex Wright

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

Information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLALLILFIL
Date   Source Headline
1st Jun 20215:13 pmRNSBlock Listing Six Monthly Return
26th May 202111:57 amRNSDirector Declaration
20th May 20213:57 pmRNSDirector Declaration
19th May 20217:00 amEQSTreatt (TET): Sweet upgrades
12th May 20214:35 pmRNSHolding(s) in Company
11th May 20216:02 pmRNSHalf Year Results – Replacement
11th May 20217:00 amRNSHalf Year Results
21st Apr 20213:46 pmRNSHolding(s) in Company
12th Apr 20217:00 amRNSTrading Update
9th Apr 20214:32 pmRNSHolding(s) in Company
1st Apr 20214:18 pmRNSTotal Voting Rights
22nd Mar 20215:35 pmRNSDirector/PDMR Shareholding
26th Feb 20217:00 amRNSAppointment of Joint Broker
23rd Feb 20213:33 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSHolding(s) in Company
29th Jan 20211:59 pmRNSResult of AGM
22nd Jan 20217:00 amRNSTrading Update
13th Jan 20214:40 pmRNSDirector/PDMR Shareholding
12th Jan 20213:20 pmRNSDirector/PDMR Shareholding
11th Jan 20219:27 amRNSDirector Declaration
21st Dec 20203:23 pmRNSTotal Voting Rights
21st Dec 202010:28 amRNSChanges to 2021 AGM Arrangements
16th Dec 20205:16 pmRNSDirector/PDMR Shareholding
11th Dec 20201:30 pmRNSBlock Listing Return
10th Dec 20205:21 pmRNSBlock Listing Return
8th Dec 202011:04 amRNSAnnual Financial Report
24th Nov 20207:00 amRNSFull Year Results
4th Nov 20202:30 pmRNSHolding(s) in Company
22nd Oct 20204:41 pmRNSHolding(s) in Company
9th Oct 20207:00 amRNSTrading Statement
2nd Oct 202012:45 pmRNSVoting Rights and Capital
24th Sep 20202:26 pmRNSNotification of Transaction of a Director
22nd Sep 20207:00 amRNSNotice of Trading Update
14th Sep 20207:00 amRNSDirector/PDMR Shareholding
1st Sep 20205:27 pmRNSDirector/PDMR Shareholding
26th Aug 20209:29 amRNSBoard Appointment and Board Committee Changes
17th Aug 20205:20 pmRNSDirector/PDMR Shareholding
14th Aug 20205:26 pmRNSDirector/PDMR Shareholding
13th Aug 20204:09 pmRNSHolding(s) in Company
8th Jul 202012:34 pmRNSDirector/PDMR Shareholding
22nd Jun 20202:57 pmRNSHolding(s) in Company
18th Jun 20202:18 pmRNSHolding(s) in Company
15th Jun 20204:57 pmRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
1st Jun 202012:32 pmRNSBlock Listing Six Monthly Return
1st Jun 202012:31 pmRNSBlock Listing Six Monthly Return
29th May 20204:27 pmRNSChange of Auditor
22nd May 20202:11 pmRNSDirector Declaration
22nd May 20207:00 amRNSDirector/PDMR Shareholding
19th May 20204:46 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.